18results
-
Press
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
-
Press
SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in CBM
-
Press
SK Inc.’s board of directors declares an interim dividend of KRW 1,500 per share
-
Press
SK pharmteco doubles viral vector production capacity in Europe
-
Press
SK Inc.-SK innovation-Korea Hydro & Nuclear Power Sign MOU to Cooperate in Clean Energy Business
-
Press
SK Inc.’s subsidiary Yes Power Technix renames itself to SK powertech
-
Press
SK Inc. Holds Annual General Meeting (AGM) of Shareholders
-
Press
SK Inc. to bolster its investment in future mobility in the fast growing Southeast Asian market
-
Press
SK Inc. hosts “SK Bio Night” in San Francisco to expand global partnerships